{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:53:28Z","timestamp":1793195608165,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Remimazolam, an ultrashort-acting benzodiazepine, allows for rapid and reliable arousal. Rapid awakening using remimazolam may be beneficial in transcatheter aortic valve replacement (TAVR), as it allows rapid detection of neurologic deficits. The purpose of this study was to compare arousal time and outcomes between monitored anesthesia care (MAC) with remimazolam and remifentanil and conventional MAC with dexmedetomidine, propofol, and remifentanil. This study was a single center retrospective study. All TAVR cases performed under MAC (MAC-TAVR) at our institution between 2019 and 2021 were included. Patients were classified by anesthesia method into remimazolam and dexmedetomidine groups. Among 258 MAC-TAVR patients, 253 were enrolled. After propensity score matching, 76 patients were assigned to each group. The time from end of drug-administration to arousal [20.0 (16.0, 24.0) min vs. 38.5 (30.0, 56.3) min, p\u2009&lt;\u20090.0001] and the time from attempted-arousal to arousal [1.0 (1.0, 1.0) min vs. 12.5 (3.0, 26.8) min, p\u2009&lt;\u20090.0001] were significantly shorter in the remimazolam group. There was no significant difference in the length of ICU stay [2.0 (2.0, 2.0) days vs. 2.0 (2.0, 2.0) days, p\u2009=\u20090.157] and postoperative hospital stay [6.0 (4.0, 9.0) days vs. 5.0 (4.0, 8.0) days, p\u2009=\u20090.262].<\/jats:p>\n                  <jats:p>\n                    Trial registration: Clinical trial number: R03-123, \nRegistry URL:\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/center6.umin.ac.jp\/cgi-open-bin\/ctr\/ctr_view.cgi?recptno=R000051635\">https:\/\/center6.umin.ac.jp\/cgi-open-bin\/ctr\/ctr_view.cgi?recptno=R000051635<\/jats:ext-link>\n                    Registration number: UMIN000045195, Principal investigator's name: Atsuhiro Kitaura,\nDate of registration: 20 August 2021.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-43895-0","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T06:02:16Z","timestamp":1696917736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A retrospective comparative study of anesthesia with remimazolam and remifentanil versus dexmedetomidine and remifentanil for transcatheter aortic valve replacement"],"prefix":"10.1038","volume":"13","clinical-trial-number":[{"clinical-trial-number":"umin000045195","registry":"10.18810\/umin-japan"}],"author":[{"given":"Atsuhiro","family":"Kitaura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Tsukimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroatsu","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Hamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,10]]},"reference":[{"key":"43895_CR1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00540-020-02788-6","volume":"34","author":"M Doi","year":"2020","unstructured":"Doi, M. et al. Efficacy and safety of remimazolam versus propofol for general anesthesia: A multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial. J. Anesth. 34, 543\u2013553 (2020).","journal-title":"J. Anesth."},{"key":"43895_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/01.anes.0000267503.85085.c0","volume":"107","author":"GJ Kilpatrick","year":"2007","unstructured":"Kilpatrick, G. J. et al. CNS 7056. Anesthesiology 107, 60\u201366 (2007).","journal-title":"Anesthesiology"},{"issue":"2","key":"43895_CR3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1213\/ANE.0b013e318241f68a","volume":"115","author":"HR Whilyshire","year":"2012","unstructured":"Whilyshire, H. R., Kilpatrick, G. J., Tilbrook, G. S. & Borkett, K. M. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation. Anesth. Analgesia 115(2), 284\u2013296 (2012).","journal-title":"Anesth. Analgesia"},{"issue":"4","key":"43895_CR4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/jcph.1552","volume":"60","author":"LL Lohmer","year":"2020","unstructured":"Lohmer, L. L., Schippers, F., Petersen, K. U., Stoehr, T. & Schmith, V. D. Time-to-event modeling for remimazolam for the indication of induction and maintenance of general anesthesia. J. Clin. Pharmacol. 60(4), 505\u2013514 (2020).","journal-title":"J. Clin. Pharmacol."},{"key":"43895_CR5","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/j.jacc.2020.09.595","volume":"76","author":"JD Carroll","year":"2020","unstructured":"Carroll, J. D. et al. STS-ACC TVT registry of transcatheter aortic valve replacement. J. Am. Coll. Cardiol. 76, 2492\u20132516 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"43895_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4103\/0971-9784.91484","volume":"15","author":"A Franco","year":"2012","unstructured":"Franco, A., Gerli, C., Ruggeri, L. & Monaco, F. Anaesthetic management of transcatheter aortic valve implantation. Ann. Cardiac Anaesth. 15, 54\u201363 (2012).","journal-title":"Ann. Cardiac Anaesth."},{"key":"43895_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2147\/LRA.S230728","volume":"13","author":"M Cascella","year":"2020","unstructured":"Cascella, M., Bimonte, S. & Di Napoli, R. Delayed emergence from anesthesia: What we know and how we act. Local Region. Anesth. 13, 195\u2013206 (2020).","journal-title":"Local Region. Anesth."},{"key":"43895_CR8","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1136\/heartjnl-2017-312559","volume":"104","author":"M Eskandari","year":"2018","unstructured":"Eskandari, M. et al. Comparison of general anesthesia and non-general anesthesia approach in transfemoral transcatheter aortic valve implantation. Heart 104, 1621\u20131628 (2018).","journal-title":"Heart"},{"key":"43895_CR9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jcin.2017.12.019","volume":"11","author":"O Husser","year":"2018","unstructured":"Husser, O. et al. Conscious sedation versus general anesthesia in transcatheter aortic valve replacement: The German Aortic Valve Registry. JACC Cardiovasc. Interv. 11, 567\u2013578 (2018).","journal-title":"JACC Cardiovasc. Interv."},{"key":"43895_CR10","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s12325-020-01342-w","volume":"37","author":"L Cristiano","year":"2020","unstructured":"Cristiano, L. et al. Use of dexmedetomidine in transfemoral aortic valve implantation procedures. Adv. Ther. 37, 2337\u20132343 (2020).","journal-title":"Adv. Ther."},{"key":"43895_CR11","unstructured":"Lehmann, E.L. Nonparametrics: Statistical Methods Based on Ranks. 76\u201381 (Springer, 1998)"},{"key":"43895_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1471-2288-12-70","volume":"12","author":"R Pirracchio","year":"2012","unstructured":"Pirracchio, R., Resche-Rigon, M. & Chevret, S. Evaluation of the Propensity score methods for estimating marginal odds ratios in case of small sample size. BMC Med. Res. Methodol. 12, 70 (2012).","journal-title":"BMC Med. Res. Methodol."},{"key":"43895_CR13","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2165\/11207190-000000000-00000","volume":"71","author":"SM Hoy","year":"2011","unstructured":"Hoy, S. M. & Keating, G. M. Dexmedetomidine: A review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation. Drugs 71, 1481\u20131501 (2011).","journal-title":"Drugs"},{"key":"43895_CR14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ijsu.2015.04.079","volume":"18","author":"NJ Hackett","year":"2015","unstructured":"Hackett, N. J., De Oliveira, G. S., Jain, U. K. & Kim, J. Y. ASA class is a reliable independent predictor of medical complications and mortality following surgery. Int. J. Surg. 18, 184\u2013190 (2015).","journal-title":"Int. J. Surg."},{"issue":"4","key":"43895_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00540-020-02776-w","volume":"34","author":"M Doi","year":"2020","unstructured":"Doi, M. et al. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): Results of a multicenter, randomized, double-blind, parallel-group comparative trial. J. Anesth. 34(4), 491\u2013501 (2020).","journal-title":"J. Anesth."},{"key":"43895_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/s00415-015-8010-2","volume":"263","author":"K Schurmann","year":"2016","unstructured":"Schurmann, K. et al. Risk profile and treatment options of acute ischemic in-hospital stroke. J. Neurol. 263, 550\u2013557 (2016).","journal-title":"J. Neurol."},{"key":"43895_CR17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12871-022-01770-x","volume":"22","author":"SW Song","year":"2022","unstructured":"Song, S. W., Jang, Y. N., Yoon, M. W. & Jeon, Y. G. Quality of recovery in patients administered remimazolam versus those administered an inhalant agent for the maintenance of general anesthesia: A randomized control trial. BMC Anesthesiol. 22, 226 (2022).","journal-title":"BMC Anesthesiol."},{"issue":"4","key":"43895_CR18","first-page":"256","volume":"89","author":"F Monaco","year":"2013","unstructured":"Monaco, F. et al. Dexmedetomidine versus remifentanil for sedation under monitored anesthetic care in complex endvascular aortic aneurysm repair: A single center experience with mid-term follow-up. Minerva Anesthesiol. 89(4), 256\u2013264 (2013).","journal-title":"Minerva Anesthesiol."},{"key":"43895_CR19","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.2147\/DDDT.S373772","volume":"16","author":"Y Deng","year":"2022","unstructured":"Deng, Y. et al. Efficacy and safety of remimazolam besylate versus dexmedetomidine for sedation in non-intubated older patients with agitated delirium after orthopedic surgery: A randomized controlled trial. Drug Des. Dev. Ther. 16, 2439\u20132451 (2022).","journal-title":"Drug Des. Dev. Ther."},{"issue":"10","key":"43895_CR20","volume":"14","author":"H Ito","year":"2022","unstructured":"Ito, H. et al. Anesthetic management using remimazolam for transcatheter edge-to-edge repair of the mitral valve in patients with reduced ejection fraction: A case report of two cases. Cureus 14(10), e30706 (2022).","journal-title":"Cureus"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43895-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43895-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43895-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T18:22:40Z","timestamp":1700504560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-43895-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,10]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["43895"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-43895-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2661590\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,10]]},"assertion":[{"value":"6 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17074"}}